fda tirzepatide approval Grants a New Indication for Obesity Management Zepbound™ (tirzepatide): The Latest FDA-Approved

Mounjaro is a double-action drug that mimics two hormones, GLP-1 and GIP

Jooste, C.S

GLP-1 short-term side effects include: Nausea Vomiting Diarrhea Constipation Headaches Fatigue Dizziness GLP-1 long-term side effects include: Ongoing and persistent irregular bowel movements Sluggish digestion Changes in gut comfort over time Impact on bone health and density Reduction in muscle mass Nutritional deficiencies Its important to note that long-term GLP-1 medication side effects have not been well-studied

Studies evaluating modified fasting strategies, including a 24-hour liquid-only diet, reported low complication rates without the need for routine medication discontinuation